Verda J. Hunter

The Use of Antioxidants with First-Line Chemotherapy in Two Cases of Ovarian Cancer

Jeanne Drisko, Julia Chapman, Verda J. Hunter · Journal of the American College of Nutrition · 2003 · 146 citations

Oral Antioxidant Therapy, Chemoprevention Strategy, Medicine +15

Preoperative serum tumor-associated antigen levels in women with pelvic masses.

John T. Soper, Verda J. Hunter, L. Daly et al. · PubMed · 1990 · 67 citations

Surgical Oncology, Tumoral Pathology, Gynecological Surgery +14

Tumor necrosis factor-α alters steroidogenesis and stimulates proliferation of human ovarian granulosal cells in vitro

Yan Zongzhe, Verda J. Hunter, John C. Weed et al. · Fertility and Sterility · 1993 · 62 citations

Inflammation, Granulocyte, Immunology +9

The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction

Verda J. Hunter, L. Daly, Michael J. Helms et al. · American Journal of Obstetrics and Gynecology · 1990 · 51 citations

Surgical Oncology, Ca 125, Medicine +8

Phase II Trial of Oral Altretamine for Consolidation of Clinical Complete Remission in Women with Stage III Epithelial Ovarian Cancer: A Southwest Oncology Group Trial (SWOG-9326)

Mace L. Rothenberg, P.Y. Liu, Sharon P. Wilczynski et al. · Gynecologic Oncology · 2001 · 34 citations

Oral Altretamine, Oncology, Phase Ii Trial +9